Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marianne Skeie

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Journal of Cellular and Molecular Medicine|July 17, 2020
Hsp90 inhibition and co-incubation with pertuzumab induce internalization and degradation of trastuzumab: Implications for use of T-DM1Marianne Skeie, Filip Nikolaysen, Ylenia Chitano, et al.
Microbiology (Reading, England)|December 8, 2004
Characterization of the Bacillus cereus Nhe enterotoxinToril Lindbäck, Annette Fagerlund, Marianne Skeie Rødland, et al.
Experimental Cell Research|June 25, 2019
Protein kinase C regulates ErbB3 turnoverMarkus Dietrich, Muhammad Salman Malik, Marianne Skeie, et al.
Experimental Cell Research|August 12, 2018
Protein kinase C mediated internalization of ErbB2 is independent of clathrin, ubiquitination and Hsp90 dissociationMarkus Dietrich, Muhammad Salman Malik, Filip Nikolaysen, et al.
Pharmaceuticals (Basel, Switzerland)|November 28, 2013
Pertuzumab Increases 17-AAG-Induced Degradation of ErbB2, and This Effect Is Further Increased by Combining Pertuzumab with TrastuzumabJuliana Bentes Hughes, Marianne Skeie Rødland, Max Hasmann, et al.
Experimental Cell Research|February 12, 2008
Dysregulation of Ack1 inhibits down-regulation of the EGF receptorLene Melsaether Grøvdal, Lene E Johannessen, Marianne Skeie Rødland, et al.
Experimental Cell Research|November 7, 2012
Preubiquitinated chimeric ErbB2 is constitutively endocytosed and subsequently degraded in lysosomesTram Thu Vuong, Christian Berger, Vibeke Bertelsen, et al.
Molecular Cancer Research : MCR|February 12, 2009
Expression of epidermal growth factor receptor or ErbB3 facilitates geldanamycin-induced down-regulation of ErbB2Nina Marie Pedersen, Kamilla Breen, Marianne Skeie Rødland, et al.
Molecular Cancer Therapeutics|July 9, 2009
Pertuzumab increases epidermal growth factor receptor down-regulation by counteracting epidermal growth factor receptor-ErbB2 heterodimerizationJuliana Bentes Hughes, Christian Berger, Marianne Skeie Rødland, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research|September 5, 2017
ErbB3 interacts with Hrs and is sorted to lysosomes for degradationAnne Marthe Fosdahl, Markus Dietrich, Kay Oliver Schink, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Journal of Cellular and Molecular Medicine|July 17, 2020
Hsp90 inhibition and co-incubation with pertuzumab induce internalization and degradation of trastuzumab: Implications for use of T-DM1Marianne Skeie, Filip Nikolaysen, Ylenia Chitano, et al.
Microbiology (Reading, England)|December 8, 2004
Characterization of the Bacillus cereus Nhe enterotoxinToril Lindbäck, Annette Fagerlund, Marianne Skeie Rødland, et al.
Experimental Cell Research|June 25, 2019
Protein kinase C regulates ErbB3 turnoverMarkus Dietrich, Muhammad Salman Malik, Marianne Skeie, et al.
Experimental Cell Research|August 12, 2018
Protein kinase C mediated internalization of ErbB2 is independent of clathrin, ubiquitination and Hsp90 dissociationMarkus Dietrich, Muhammad Salman Malik, Filip Nikolaysen, et al.
Pharmaceuticals (Basel, Switzerland)|November 28, 2013
Pertuzumab Increases 17-AAG-Induced Degradation of ErbB2, and This Effect Is Further Increased by Combining Pertuzumab with TrastuzumabJuliana Bentes Hughes, Marianne Skeie Rødland, Max Hasmann, et al.
Experimental Cell Research|February 12, 2008
Dysregulation of Ack1 inhibits down-regulation of the EGF receptorLene Melsaether Grøvdal, Lene E Johannessen, Marianne Skeie Rødland, et al.
Experimental Cell Research|November 7, 2012
Preubiquitinated chimeric ErbB2 is constitutively endocytosed and subsequently degraded in lysosomesTram Thu Vuong, Christian Berger, Vibeke Bertelsen, et al.
Molecular Cancer Research : MCR|February 12, 2009
Expression of epidermal growth factor receptor or ErbB3 facilitates geldanamycin-induced down-regulation of ErbB2Nina Marie Pedersen, Kamilla Breen, Marianne Skeie Rødland, et al.
Molecular Cancer Therapeutics|July 9, 2009
Pertuzumab increases epidermal growth factor receptor down-regulation by counteracting epidermal growth factor receptor-ErbB2 heterodimerizationJuliana Bentes Hughes, Christian Berger, Marianne Skeie Rødland, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research|September 5, 2017
ErbB3 interacts with Hrs and is sorted to lysosomes for degradationAnne Marthe Fosdahl, Markus Dietrich, Kay Oliver Schink, et al.
Pageof 2